Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
The Journal of Investigative Dermatology|November 20, 2009
Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesisBernice Y Kwong, Scott J Roberts, Tobias Silberzahn, et al.Journal of the American Academy of Dermatology|August 31, 2018
Clinical spectrum of cutaneous melanoma morphologyNikolai Klebanov, Nicole S Gunasekera, William M Lin, et al.JAMA Dermatology|October 18, 2023
Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma PrognosisPaul R Massey, David M Wang, Fadi Murad, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2014
Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injuryChristine Guo Lian, Ericka M Bueno, Scott R Granter, et al.Molecular Cancer Research : MCR|August 13, 2009
Oncogenic activating mutations are associated with local copy gainBarmak Modrek, Lin Ge, Ajay Pandita, et al.Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.The Journal of Investigative Dermatology|September 2, 2011
Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patientsWilliam M Lin, Julia M Lewis, Renata B Filler, et al.Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.Cancer Research|February 5, 2008
Modeling genomic diversity and tumor dependency in malignant melanomaWilliam M Lin, Alissa C Baker, Rameen Beroukhim, et al.Nature|March 25, 2011
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetCraig J Ceol, Yariv Houvras, Judit Jane-Valbuena, et al.Pageof 3